The use of vaginal rings may have been one of the most convenient ways of preventing unplanned pregnancies, according to a women’s survey. There are several possible reasons for which some women may not be able to use the small plastic rings, but news about the NuvaRing contraceptive lawsuits has also made public the dangers of such birth control method. In most cases, when a woman has had certain health conditions, her health care provider might not prescribe it because of the following:
Has had a blood clot clogging the vein or artery.
Suffering from hyperglycemia.
Had breast cancer.
Weak vaginal muscles.
Has just recently stopped smoking or is still smoking.
Older than 35 years old.
Has a heart or circulatory problem.
Having one or two of these conditions requires the woman to consider other alternatives. Careful consideration may help prevent any complications in the future.
DePuy Orthopaedics, a subsidiary of Johnson & Johnson, introduced the ASR XL Acetabular System and the ASR Hip Resurfacing System in 2005 after getting clearance from the Food and Drug Administration through the 510(k) premarket notification process. After five years in the market and numerous complaints of severe complications, these systems have been the subject of a DePuy hip replacement recall around the world.
Studies have shown that these systems have a defect in its design, which may cause early deterioration and even complete failure. It has been estimated that as high as 12 percent of the patients require revision surgeries after implanting these devices. In the United Kingdom, failure rate was pegged at a very high 49 percent.
This product deterioration has allegedly caused pseudotumors when small metal particles enter the person’s bloodstream. Loosening of the parts may result to fractures and dislocations causing pain, swelling, and difficulty in walking. These side effects have been described as very serious, which requires several revision surgeries.
Overweight or obese men are most likely to need a hip replacement than men who are of average weight, medical experts say. Overweight is a known risk factor for osteoarthritis. Talking about osteoarthritis, it is actually treated with hip replacement surgery, and lately there have been alteration of Stryker hip implant surgeries done for reasons of inefficiency.
But this is the first study that revealed being overweight is a risk factor for hip osteoarthritis in men but not in women.
According to an online article, the Annals of Rheumatic Diseases, researchers compared the BMIs (body mass index) of 1,473 Icelandic people who had hip or knee replacements with those of 1,103 people who had never undergone joint replacement surgery. All of the study participants were born between 1910 and 1939.
Study results showed that women who were classified as overweight (BMI greater than 25) were no more likely to have a hip replacement than women of normal weight. However, men who were obese (BMI greater than 30) were 70 percent more likely to have had hip replacement surgery. Men and women who were overweight were more likely to have had knee replacement surgery than those of normal weight, five times more likely in obese men and four times more in women.
The considerable discomfort and wide range of symptoms involving pelvic and bladder problems account for many cases in which numerous women seek treatment with or without surgery, medical experts say. However, where a surgical repair using mesh and bladder slings is involved, complaints of serious complications have been reported, eliciting a growing number of lawsuits against the device makers, some of which are reportedly calling for a possible surgical mesh sling product recall.
As a result, the United States Food and Drug Administration (FDA) released a public health advisory in 2008 alerting physicians and patients alike of the rare medical consequences involving the serious complications associated with mesh and bladder sling devices placed surgically for the treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). As reports of adverse events continued to increasingly prevail, the agency was found overturning this warning in 2011, explaining that complications stemming from these medical devices, specifically for POP repair, are common.
Whenever we are down and sick, drugs help us to get back in shape, still, there are also the bad side of it, just like Zoloft which kept silent about its serious effects to its users.From the selective serotonin reuptake inhibitor (SSRI) class of drug, Zoloft is used for the management of major depression. If you are pregnant and under Zoloft medication, be alert of the effects your baby might encounter. There are certain birth defects caused by Zoloft when you are taking it during your pregnancy.
The following are considered the most common birth defects associated with Zoloft:
Atrial septal defects (ASD)
Persistent pulmonary hypertension of the newborn (PPHN)
Omphalocele (an abdominal defect)
Craniosynotostosis (skull defects)
Tetralogy of fallot (TOF) with pulmonary atresia
Transposition of the great arteries
Congenital heart defects
Ventricular septal defects (VSD)
These disorders are possibly dangerous and might be fatal. As a mother to a child suffering from any of these disorders, of course it is heart-breaking and hard for them to accept. Not to mention, that they are going to shoulder the bills for the treatment of their child.
Thousands of dialysis patients have experienced life-threatening cardiac problems such as heart attack, stroke, cardiac arrest, or cardiovascular death after they were administered with GranuFlo or NaturaLyte. The two concentrates are products created by Fresenius Medical Care and are mixed with other substances for people undergoing hemodialysis.
Fresenius, a Germany-based company which owns a number of clinics and dialysis centers all over the United States may have breached federal regulations for not warning doctors and dialysis patients of the potentially lethal side effects their products can cause.
NaturaLyte and GranuFlocontain acetate which is converted to bicarbonate by the body. Compared to rival products, however, NaturaLyte and GranuFlo have a lot more acetate, thus, resulting to more bicarbonate in the body. High levels of bicarbonate can lead to alkalosis which increases the patient’s chances of having a devastating cardiac arrest.
In June 2012, more than 900 dialysis patients have died due to sudden cardiac arrest while undergoing hemodialysis in clinics owned by Fresenius. After the incident, an analysis was conducted and results showed the patients had high levels of bicarbonate in their blood. Studies have also showed GranuFlo and NaturaLyte increases the chances of cardiac arrest by as much as six times. Family members of those who died have filed cases against Fresenius. The number of GranuFlo lawsuit is expected to increase by early 2013.
In November 2011, Fresenius sent a memo to doctors who worked at the company’s affiliate clinics. The memo warned the clinics’ staff that failure to use GranuFlo properly can increase the risk of patients dying from sudden cardiac arrest. Doctors were also advised to urgently address the matter.
Although the problem was urgent, Fresenius did not inform independent dialysis centers that were not part of their conglomerate. Those centers, however, purchased medication and dialysis machines from Fresenius.
The Food and Drug Administration (FDA) found out about the memo and conducted an investigation. Eventually, the agency issued a Class 1 recall for NaturaLyte and GranuFlo and is studying whether the company violated federal safety regulations for not warning customer clinics of the heart risks posed by the two dialysates.
A variety of social networking sites can be found on the internet which boosts personal online branding which includes Facebook, Pinterest, Twitter and now Google Plus. Google’s latest offering have increased its buzz among search engine optimization pundits because of its features that help increase online personality and credibility. Since its debut, it has served as an avenue of information and advertisement, which more than served as a form of social expression and networking. Because of these purposes, Google Plus has gained drastic consciousness among online users and has easily seeped its way to popularity. An article published in Reuters even said that “one thing that’s clear about Google is that they’ve mastered the art of subterfuge.”
According to the Reuters article, Google is betting that its approach to privacy and extensive controls over who you share information with on the network will set Google Plus apart. Google Plus is admittedly a melting pot of all the good features of other social networking sites and an improvement to their various weaknesses. Perhaps its most obvious features are predominantly derived from the strength and weaknesses of Facebook. The most effective and convenient privacy setting in Google Plus can be tested through its “circles.” Circles are your network of friends that may be categorized based on your relationships. Your circles may include your family, friends, acquaintances and colleagues. Your privacy may be regulated by allowing which circles can access information from your Google Plus profile.
All other settings may be regulated by clicking the link “Google+ settings.” By default, your settings will show that anyone in the world can access your profile, you may change the settings in order to adjust your level of trust to certain people by allowing or disallowing them to access your profile. Unlike Facebook, Google Plus’s profile is more sophisticated through its “edit your visibility on profile” setting. You may choose to customize the same.
Primarily because of these settings, Google Plus maintained its credibility and efficiency.